Curcumin: a calixarene derivative micelle potentiates anti-breast cancer stem cells effects in xenografted, triple-negative breast cancer mouse models
Triple-negative breast cancer (TNBC) is a heterogeneous and clinically aggressive disease with no approved targeted therapy. Curcumin has shown therapeutic potential against TNBC, but it shows low bioavailability and low efficacy when administered as a free drug. Here we describe a novel vehicle for...
Saved in:
Main Authors: | Wei Chen (Author), Lin Li (Author), Xiaofen Zhang (Author), Yuan Liang (Author), Zhijun Pu (Author), Lingfeng Wang (Author), Jingxin Mo (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2017-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of two cancer stem cell-like populations in triple-negative breast cancer xenografts
by: Jun Nakayama, et al.
Published: (2022) -
Functional and genomic characterisation of a xenograft model system for the study of metastasis in triple-negative breast cancer
by: Cameron N. Johnstone, et al.
Published: (2018) -
Development of Dual-Targeted Mixed Micelles Loaded with Celastrol and Evaluation on Triple-Negative Breast Cancer Therapy
by: Siying Huang, et al.
Published: (2024) -
Patient-Derived Xenografts as an Innovative Surrogate Tumor Model for the Investigation of Health Disparities in Triple Negative Breast Cancer
by: Margarite D. Matossian, et al.
Published: (2020) -
TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
by: A. D. Zikiryakhodzhaev, et al.
Published: (2017)